NAFDAC Launches Electronic Clinical Trial Application Platform

NAFDAC has launched the NAFDAC Electronic Clinical Trial Application Platform (NAFDAC-eCTAP) in partnership with NUVOTEQ and support from the Gates Foundation. This online platform is designed to provide a seamless and transparent system for submitting clinical trial applications, amendments, and progress/final reports. It also facilitates the importation of investigational medicinal products (IMP) for clinical trials. The NAFDAC-eCTAP aims to reduce turnaround times, mitigate challenges of paper-based submissions, and improve applicant’s ability to track progress. It is the first electronic application platform of its kind in Africa and can be accessed on the NAFDAC website.